PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25222F0199Typhoid VI polysaccharide vaccine — Sanofi Pasteur Inc

Sanofi Pasteur Inc holds $3.7B across 396 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 36F79722D0104. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended May 8, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

252-Network Contract Office 12 (36C252)

Awarding office

Sanofi Pasteur Inc

Recipient

May 8, 2023

PoP end

$230K

Obligated

$230K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number36C25222F0199

Also listed as36C252-22-F-0199

Also listed as36F79722D0104-36C25222F0199

Agency252-Network Contract Office 12 (36C252)

Awarding office252-Network Contract Office 12 (36C252)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentSanofi Pasteur Inc

CAGE7V915

UEINCXBGGQ8YTU9

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79722D0104

Place of performanceSWIFTWATER PA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startMay 9, 2022

PoP end (current)May 8, 2023

Obligated$230K

Current value$230K

Potential value$230K

TYPHOID VI POLYSACCHARIDE VACCINE is a federal award for 252-Network Contract Office 12 (36C252) held by Sanofi Pasteur Inc. Estimated value $230K ($230K obligated). Current period of performance ends May 8, 2023. Last award drew 1 bidder. Place of performance: SWIFTWATER PA.

Recompete timing

Public

● Past PoP end (1242 days ago)

Current PoP ended May 8, 2023 (1242 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 36C25222F0199? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Sanofi Pasteur Inc — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.7B) · all agencies · Top 4 shown (98%); remaining ~2% is other agencies.

Department of Health and Human Services (HHS)$3.6B · 97%Department of Defense (DOD)$29.1M · 1%Department of Veterans Affairs (VA)$6.9M · 0%Department of State (DOS)$2.4M · 0%

Open full company profile →

Related awards

Same parent · incumbent

15F06724F0000477

TRAVEL VACCINES.

$504K

Dec 31, 2026

15F06726F0000243

SANOFI TRAVEL VACCINES

$200K

Dec 31, 2026

75H71126F80051

THE NATIONAL SUPPLY SERVICE CENTER (NSSC), INDIAN HEALTH SERVICES (IHS), HAS A NEED FOR A …

$2.0M

Mar 14, 2027

75D30122F00001

VACCINE STORAGE AND ROTATION, 2021-2026

$163.3M

Sep 27, 2027

SPE2DP26F2910

8511928943!INFLUENZA VIRUS VAC

$3.0M

Sep 25, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25222F0199?

36C25222F0199 (Typhoid VI polysaccharide vaccine) is a 252-Network Contract Office 12 (36C252) award with a potential value of $230K, currently held by Sanofi Pasteur Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C252-22-F-0199?

36C252-22-F-0199 is the dashed form of PIID 36C25222F0199 (Typhoid VI polysaccharide vaccine), held by Sanofi Pasteur Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25222F0199?

252-Network Contract Office 12 (36C252) awarded 36C25222F0199 to Sanofi Pasteur Inc (potential $230K).

Who is the incumbent on 36C25222F0199?

Sanofi Pasteur Inc is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint. The current period of performance ends May 8, 2023.

When does Sanofi Pasteur Inc’s 36C25222F0199 come up for recompete?

SCOUT tracks a period-of-performance end of May 8, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C25222F0199? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action May 9, 2022